Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Binayak Sinha

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Expert Review of Clinical Pharmacology|April 24, 2020
Translating the statistical benefits of SGLT-2 inhibitors on cardio-renal outcomes into clinical practiceSamit Ghosal, Binayak Sinha
Frontiers in Endocrinology|March 10, 2022
A Meta-Analysis of the Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic Parameters in Patients With Polycystic Ovary SyndromeBinayak Sinha, Samit Ghosal
Diabetes & Metabolic Syndrome|March 23, 2013
Pioglitazone--do we really need it to manage type 2 diabetes?Binayak Sinha, Samit Ghosal
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 25, 2022
Assessing the Effects of Modern Renoprotective Agents in Preventing Progression of Renal Composite Outcomes in Patients with Type 2 Diabetes: A Network Meta-analysisSamit Ghosal, Binayak Sinha
Scientific Reports|September 26, 2020
Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trialsBinayak Sinha, Samit Ghosal
Diabetes Research and Clinical Practice|February 23, 2019
Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failureBinayak Sinha, Samit Ghosal
Diabetes & Metabolic Syndrome|January 3, 2017
Secondary cvd prevention-Lipid modification strategies: A critical analysisSamit Ghosal, Binayak Sinha
Journal of Diabetes Research|December 10, 2015
Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOSSamit Ghosal, Binayak Sinha
Frontiers in Endocrinology|July 20, 2023
Exploring the comparative cardiovascular death benefits of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network meta-analysis-based scoringSamit Ghosal, Binayak Sinha
Current Diabetes Reviews|February 7, 2020
Redefining Cardiovascular (CV) Death as a Primary Endpoint Component in Cardiovascular Outcome TrialsSamit Ghosal, Binayak Sinha
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Expert Review of Clinical Pharmacology|April 24, 2020
Translating the statistical benefits of SGLT-2 inhibitors on cardio-renal outcomes into clinical practiceSamit Ghosal, Binayak Sinha
Frontiers in Endocrinology|March 10, 2022
A Meta-Analysis of the Effect of Sodium Glucose Cotransporter-2 Inhibitors on Metabolic Parameters in Patients With Polycystic Ovary SyndromeBinayak Sinha, Samit Ghosal
Diabetes & Metabolic Syndrome|March 23, 2013
Pioglitazone--do we really need it to manage type 2 diabetes?Binayak Sinha, Samit Ghosal
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 25, 2022
Assessing the Effects of Modern Renoprotective Agents in Preventing Progression of Renal Composite Outcomes in Patients with Type 2 Diabetes: A Network Meta-analysisSamit Ghosal, Binayak Sinha
Scientific Reports|September 26, 2020
Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trialsBinayak Sinha, Samit Ghosal
Diabetes Research and Clinical Practice|February 23, 2019
Meta-analyses of the effects of DPP-4 inhibitors, SGLT2 inhibitors and GLP1 receptor analogues on cardiovascular death, myocardial infarction, stroke and hospitalization for heart failureBinayak Sinha, Samit Ghosal
Diabetes & Metabolic Syndrome|January 3, 2017
Secondary cvd prevention-Lipid modification strategies: A critical analysisSamit Ghosal, Binayak Sinha
Journal of Diabetes Research|December 10, 2015
Gliptins and Cardiovascular Outcomes: A Comparative and Critical Analysis after TECOSSamit Ghosal, Binayak Sinha
Frontiers in Endocrinology|July 20, 2023
Exploring the comparative cardiovascular death benefits of sodium-glucose cotransporter 2 inhibitors in type 2 diabetes: a frequentist and Bayesian network meta-analysis-based scoringSamit Ghosal, Binayak Sinha
Current Diabetes Reviews|February 7, 2020
Redefining Cardiovascular (CV) Death as a Primary Endpoint Component in Cardiovascular Outcome TrialsSamit Ghosal, Binayak Sinha
Pageof 4